Corvus Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Corvus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $33.33. The average 1-year stock price forecast is 120.29% higher than the current stock price, while the lowest is $27 (+78.45%) and the highest is $42 (+177.59%).

Price Target: $33.33 (+120.29%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$27	$33.33	$31.5	$42
Change	+78.45%	+120.29%	+108.20%	+177.59%

* Price targets were last updated on Jun 12, 2026.

Analyst Ratings

The average analyst rating for Corvus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	6	6	6	6	6	6
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Reiterates $30	Buy	Reiterates	$30	+98.28%	Jun 12, 2026
Jeff Jones Oppenheimer	Oppenheimer	Buy Reiterates $33	Buy	Reiterates	$33	+118.11%	May 15, 2026
Paul Choi Goldman Sachs	Goldman Sachs	Buy Maintains $40	Buy	Maintains	$40	+164.38%	May 15, 2026
Sean Lee CFA H.C. Wainwright	H.C. Wainwright	Buy Reiterates $27	Buy	Reiterates	$27	+78.45%	May 15, 2026
Etzer Darout Barclays	Barclays	Buy Maintains $28	Buy	Maintains	$28	+85.06%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

5.68M

EPS This Year

-0.72

from -0.54

EPS Next Year

-0.95

from -0.72

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-38.40M	-31.98M	-23.33M	-27.55M	-42.97M	-68.58M
Net Income	-43.24M	-41.31M	-27.03M	-62.29M	-15.28M	-64.00M
EPS	-	-	-	-	-0.54	-0.72
Free Cash Flow	-22.52M	-15.82M	-15.79M	13.96M	-46.86M	-62.97M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.72
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-